Jean‐pierre Lépine

Jean‐pierre Lépine's AcademicInfluence.com Rankings

Jean‐pierre Lépine

Psychology

#3294

World Rank

#3733

Historical Rank

psychology Degrees

Download Badge

Psychology

Jean‐pierre Lépine's Degrees

PhD Psychology Université Paris Cité

Why Is Jean‐pierre Lépine Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Jean‐pierre Lépine's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys. (2004) (3061)
Cross-national epidemiology of major depression and bipolar disorder. (1996) (2240)
Cross-national prevalence and risk factors for suicidal ideation, plans and attempts (2008) (2038)
Childhood adversities and adult psychopathology in the WHO World Mental Health Surveys (2010) (1849)
Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project (2004) (1835)
Cross-national epidemiology of DSM-IV major depressive episode (2011) (1674)
Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. (2007) (1275)
Concordance of the Composite International Diagnostic Interview Version 3.0 (CIDI 3.0) with standardized clinical assessments in the WHO World Mental Health Surveys (2006) (1032)
Common chronic pain conditions in developed and developing countries: gender and age differences and comorbidity with depression-anxiety disorders. (2008) (971)
The increasing burden of depression (2011) (915)
Mini International Neuropsychiatric Interview (2013) (820)
Toward a Global View of Alcohol, Tobacco, Cannabis, and Cocaine Use: Findings from the WHO World Mental Health Surveys (2008) (758)
Trauma and PTSD in the WHO World Mental Health Surveys (2017) (668)
The epidemiology of traumatic event exposure worldwide: results from the World Mental Health Survey Consortium (2015) (636)
Disability and quality of life impact of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project (2004) (601)
Prevalence of suicide ideation and suicide attempts in nine countries (1999) (579)
The European Study of the Epidemiology of Mental Disorders (ESEMeD) project: an epidemiological basis for informing mental health policies in Europe (2004) (559)
Depression in the community: the first pan‐European study DEPRES (Depression Research in European Society) (1997) (558)
Risk factors for suicidality in Europe: results from the ESEMED study. (2007) (515)
Use of mental health services in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project (2004) (512)
Development of lifetime comorbidity in the World Health Organization world mental health surveys. (2011) (432)
The cross-national epidemiology of panic disorder. (1997) (429)
Childhood Predictors of Adult Attention-Deficit/Hyperactivity Disorder: Results from the World Health Organization World Mental Health Survey Initiative (2009) (401)
Disability and treatment of specific mental and physical disorders across the world (2008) (371)
Psychotic Experiences in the General Population: A Cross-National Analysis Based on 31,261 Respondents From 18 Countries. (2015) (345)
Psychotropic drug utilization in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project (2004) (331)
The epidemiology of anxiety disorders: prevalence and societal costs. (2002) (323)
Association of childhood adversities and early-onset mental disorders with adult-onset chronic physical conditions. (2011) (311)
Gender differences in depression. Epidemiological findings from the European DEPRES I and II studies. (2002) (292)
DSM–IV personality disorders in the WHO World Mental Health Surveys (2009) (275)
12‐Month comorbidity patterns and associated factors in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project (2004) (268)
Population level of unmet need for mental healthcare in Europe (2007) (265)
Overview of key data from the European Study of the Epidemiology of Mental Disorders (ESEMeD). (2007) (265)
Evaluating the drug use "gateway" theory using cross-national data: consistency and associations of the order of initiation of drug use among participants in the WHO World Mental Health Surveys. (2010) (258)
The epidemiology of pain in depression (2004) (256)
DEPRES II (Depression Research in European Society II): a patient survey of the symptoms, disability and current management of depression in the community. DEPRES Steering Committee. (1999) (245)
Main traumatic events in Europe: PTSD in the European study of the epidemiology of mental disorders survey. (2008) (243)
Gender differences in depression (2002) (229)
Sampling and methods of the European Study of the Epidemiology of Mental Disorders (ESEMeD) project (2004) (222)
The cross-national epidemiology of social anxiety disorder: Data from the World Mental Health Survey Initiative (2017) (218)
Social Phobia in General Health Care: An Unrecognised Undertreated Disabling Disorder (1996) (216)
Cross-sectional Comparison of the Epidemiology of DSM-5 Generalized Anxiety Disorder Across the Globe (2017) (214)
The DSM-IV field trial for mixed anxiety-depression. (1994) (209)
Predictive factors of chronic Post-Traumatic Stress Disorder in rape victims (1998) (207)
Association of perceived stigma and mood and anxiety disorders: results from the World Mental Health Surveys (2008) (205)
[Evaluation of anxiety and depression among patients hospitalized on an internal medicine service]. (1985) (180)
Treatment adequacy for anxiety and depressive disorders in six European countries (2007) (177)
New treatments for cocaine dependence: a focused review. (2008) (168)
Which antidepressants have demonstrated superior efficacy? A review of the evidence (2007) (160)
Social phobia: diagnosis and epidemiology, neurobiology and pharmacology, comorbidity and treatment. (2000) (153)
What Is Causing the Reduced Drug-Placebo Difference in Recent Schizophrenia Clinical Trials and What Can be Done About It? (2008) (152)
Normative data and factor structure of the Temperament and Character Inventory (TCI) in the French version (2000) (151)
Selective attention in social phobia and the moderating effect of a concurrent depressive disorder. (2003) (144)
Remission and Relapse in the Outpatient Care of Schizophrenia: Three-year Results From the Schizophrenia Outpatient Health Outcomes Study (2006) (140)
Social Cognition and Emotional Assessment differentiates frontotemporal dementia from depression (2012) (137)
Estimating treatment coverage for people with substance use disorders: an analysis of data from the World Mental Health Surveys (2017) (133)
The Association or Otherwise of the Functional Somatic Syndromes (2007) (129)
Suicide attempts in patients with panic disorder. (1993) (127)
Associations of serious mental illness with earnings: results from the WHO World Mental Health surveys (2010) (121)
The European Study of the Epidemiology of Mental Disorders (ESEMeD/MHEDEA 2000) project: rationale and methods (2002) (119)
Tyrosine hydroxylase polymorphisms associated with manic-depressive illness (1990) (117)
Epidemiology of Depression and Anxiety Disorders (2001) (114)
Consensus statement on transcultural issues in depression and anxiety from the International Consensus Group on Depression and Anxiety. (2001) (110)
ANXIETY AND DEPRESSION IN INPATIENTS (1985) (110)
Obsessive-compulsive symptom dimensions in the general population: results from an epidemiological study in six European countries. (2010) (105)
Epidemiology, burden, and disability in depression and anxiety. (2001) (104)
Anxiety and Substance Use Disorders: Co-occurrence and Clinical Issues (2015) (103)
The cross-national epidemiology of specific phobia in the World Mental Health Surveys (2017) (103)
Relationship between Toxoplasma gondii infection and bipolar disorder in a French sample. (2013) (101)
The association between childhood adversities and subsequent first onset of psychotic experiences: a cross-national analysis of 23 998 respondents from 17 countries (2017) (97)
Anxiety but not depression is associated with elevated blood pressure in a community group of French elderly. (1999) (90)
Age of Onset and Lifetime Projected Risk of Psychotic Experiences: Cross-National Data From the World Mental Health Survey. (2016) (90)
The Role of Criterion A2 in the DSM-IV Diagnosis of Posttraumatic Stress Disorder (2010) (89)
Family burden related to mental and physical disorders in the world: results from the WHO World Mental Health (WMH) surveys. (2013) (89)
Cognitive aspects of social phobia: a review of theories and experimental research (2000) (87)
Early cannabis use and estimated risk of later onset of depression spells: Epidemiologic evidence from the population-based World Health Organization World Mental Health Survey Initiative. (2010) (87)
Citalopram in doses of 20–60 mg is effective in depression relapse prevention: a placebo‐controlled 6 month study (1995) (83)
Role of common mental and physical disorders in partial disability around the world. (2012) (82)
Trauma and psychotic experiences: transnational data from the World Mental Health Survey (2017) (80)
Anxiety and depressive disorders in fathers and mothers of anxious school-refusing children. (1999) (80)
Patterns of neuroleptic drug prescription: a national cross-sectional survey of a random sample of French psychiatrists. (2001) (79)
Identification of depressed patient types in the community and their treatment needs: findings from the DEPRES II (Depression Research in European Society II) survey. DEPRES Steering Committee. (1999) (79)
Pediatric-Onset and Adult-Onset Separation Anxiety Disorder Across Countries in the World Mental Health Survey. (2015) (78)
Social phobia and alcoholism: a complex relationship. (1998) (74)
Panic disorder in cardiac outpatients. (1993) (71)
Association Between Psychotic Experiences and Subsequent Suicidal Thoughts and Behaviors: A Cross-National Analysis From the World Health Organization World Mental Health Surveys (2017) (71)
A randomized, placebo-controlled trial of sertraline for prophylactic treatment of highly recurrent major depressive disorder. (2004) (68)
Cross-national differences in the prevalence and correlates of burden among older family caregivers in the World Health Organization World Mental Health (WMH) Surveys (2012) (65)
Associations between DSM-IV mental disorders and diabetes mellitus: a role for impulse control disorders and depression (2014) (64)
Associations between DSM-IV mental disorders and subsequent heart disease onset: beyond depression. (2013) (64)
Personality dimensions in social phobics with or without depression (2002) (63)
[Epidemiology of the use of anxiolytic and hypnotic drugs in France and in the world]. (1996) (63)
[Prevalence and comorbidity of psychiatric disorders in the French general population]. (2005) (61)
Subtyping social anxiety disorder in developed and developing countries (2010) (60)
Pharmacology of Morphine in Obese Patients (2009) (59)
Association between mental disorders and subsequent adult onset asthma. (2014) (58)
Methadone dose in heroin-dependent patients: role of clinical factors, comedications, genetic polymorphisms and enzyme activity. (2015) (55)
Classification and epidemiology of social phobia (2005) (53)
Lifetime and current comorbidity of anxiety and depressive disorders: Results from the International WHO/ADAMHA CIDI Field Trials (1993) (52)
Screening for Alzheimer’s Disease with the Short Cognitive Evaluation Battery (2003) (51)
Self-reported psychotropic drug use and associated factors in a French community sample (1992) (50)
[Psychotropic drug use and mental psychiatric disorders in France; results of the general population ESEMeD/MHEDEA 2000 epidemiological study]. (2005) (49)
Pharmacological treatment and other predictors of treatment outcomes in previously untreated patients with schizophrenia: results from the European Schizophrenia Outpatient Health Outcomes (SOHO) study (2005) (49)
Cognitive deterioration among bipolar disorder patients infected by Toxoplasma gondii is correlated to interleukin 6 levels. (2015) (48)
The reliability of the SADS-LA in a family study setting (2005) (48)
Brain-derived neurotrophic factor Val66Met polymorphism and 6-month antidepressant remission in depressed Caucasian patients. (2015) (47)
Epidemiology of depression in the elderly (1998) (47)
Fluoxetine treatment of trichotillomania. (1991) (47)
The associations between psychotic experiences and substance use and substance use disorders: findings from the World Health Organization World Mental Health surveys (2018) (46)
Relationship between attempted suicide, serum cholesterol level and novelty seeking in psychiatric in-patients (2002) (46)
Treating major depressive episodes with antidepressants can induce or worsen metabolic syndrome: results of the METADAP cohort (2015) (45)
Bromocriptine in affective disorders. A pilot study. (1979) (45)
Social phobia in the community: relationship between diagnostic threshold and prevalence (2000) (43)
Tianeptine and paroxetine in major depressive disorder, with a special focus on the anxious component in depression: an international, 6‐week double‐blind study † (2001) (43)
High and low suicidality in Europe: a fine-grained comparison of France and Spain within the ESEMeD surveys. (2011) (42)
Converging translational evidence for the involvement of the serotonin 2A receptor gene in major depressive disorder (2014) (42)
Anxiety and depressive disorders in a French population: methodology and preliminary results (1989) (40)
Subsyndromal (“Mixed”) anxiety-depression in primary care (1994) (39)
Social phobia in general health care (1994) (39)
[Comparison of various tools for evaluating depression apropos of a study on Athymil 30 mg]. (1984) (39)
Implications of modifying the duration requirement of generalized anxiety disorder in developed and developing countries (2008) (39)
Effects of Cumulative Herpesviridae and Toxoplasma gondii Infections on Cognitive Function in Healthy, Bipolar, and Schizophrenia Subjects. (2017) (38)
Consensus statement on the benefit to the community of ESEMeD (European Study of the Epidemiology of Mental Disorders) survey data on depression and anxiety. (2007) (37)
Cocaine-induced psychotic symptoms in French cocaine addicts (2012) (37)
[Evaluation of the psychometric properties of the French version of the Tridimensional Personality Questionnaire (TPQ)]. (1994) (34)
General practice-based intervention for suspecting and detecting dementia in France (2008) (34)
Complementary and alternative medicine contacts by persons with mental disorders in 25 countries: results from the World Mental Health Surveys (2017) (33)
Symptomatic remission in previously untreated patients with schizophrenia: 2-year results from the SOHO study (2007) (33)
Amisulpride does not prevent relapse in primary alcohol dependence: results of a pilot randomized, placebo-controlled trial. (2002) (33)
Defining bipolar mood states with quantitative measurement of inhibition/activation and emotional reactivity. (2010) (33)
Exposure to Traumatic Events and Posttraumatic Stress Disorder in France: Results From the WMH Survey. (2015) (33)
[Antidepressants consumption in the global population in France]. (2002) (32)
The epidemiology of drug use disorders cross-nationally: Findings from the WHO's World Mental Health Surveys. (2019) (32)
[Validation of a French version of the General Health Questionnaire (GHQ-28) in a diabetic population]. (1993) (32)
Cytomegalovirus seropositivity and serointensity are associated with hippocampal volume and verbal memory in schizophrenia and bipolar disorder (2014) (32)
Posttraumatic stress disorder associated with unexpected death of a loved one: Cross‐national findings from the world mental health surveys (2017) (31)
Could the inter-individual variability in cocaine-induced psychotic effects influence the development of cocaine addiction? Towards a new pharmacogenetic approach to addictions. (2010) (31)
Disability Mediates the Impact of Common Conditions on Perceived Health (2013) (30)
Cross-National Comparisons of Sex Differences in Opportunities to Use Alcohol or Drugs, and the Transitions to Use (2011) (29)
Diagnosis and Epidemiology of Agoraphobia and Social Phobia (1995) (29)
[Does addiction to antidepressants exist? About a case of one addiction to tianeptine]. (2003) (29)
Comorbidity and social phobia: clinical and epidemiological issues (1996) (28)
Embarrassment when illness strikes a close relative: a World Mental Health Survey Consortium Multi-Site Study (2013) (28)
PANIC AND HYPERTENSION ASSOCIATED WITH SINGLE DOSE OF BUSPIRONE (1989) (27)
Childhood predictors of adult ADHD : Results from the WHO World Mental Health ( WMH ) Survey Initiative (2009) (26)
Psychotic experiences and general medical conditions: a cross-national analysis based on 28 002 respondents from 16 countries in the WHO World Mental Health Surveys (2018) (26)
Test–retest reliability of the Temperament and Character Inventory in patients with opiate dependence (2003) (25)
Pilot Study Examining the Frequency of Several Gene Polymorphisms Involved in Morphine Pharmacodynamics and Pharmacokinetics in a Morbidly Obese Population (2011) (25)
The symptom check-list 90R (SCL-90R) in a french general psychiatric 708 outpatient sample: is there a factor structure? (1989) (25)
Remission in the outpatient care of schizophrenia: 3-Year results from the Schizophrenia Outpatients Health Outcomes (SOHO) Study in France (2008) (25)
Suicide ideation across reproductive life cycle of women. Results from a European epidemiological study. (2009) (25)
MRI exploration of pineal volume in bipolar disorder. (2011) (25)
Associations between DSM-IV mental disorders and subsequent self-reported diagnosis of cancer. (2014) (24)
[Mental disorders and migraine: epidemiologic studies]. (1999) (23)
Validation of a computerized version of the temperament and character inventory (TCI) in psychiatric inpatients (1997) (22)
Efficacy, safety, and indications for tricyclic and newer antidepressants (1994) (22)
A cannabinoid receptor 1 polymorphism is protective against major depressive disorder in methadone-maintained outpatients. (2015) (22)
[The Fear of Negative Evaluation scale (FNE): psychometric properties of the French version]. (2004) (22)
What Happens to Depressed Men? Application of the Stirling County Criteria (1997) (22)
The association between psychotic experiences and health-related quality of life: a cross-national analysis based on World Mental Health Surveys (2018) (21)
Psychotic experiences and religiosity: data from the WHO World Mental Health Surveys (2018) (21)
Regional differences in treatment response and three year course of schizophrenia across the world. (2012) (21)
Serious suicide attempts in outpatients with multiple substance use disorders. (2017) (21)
An open-label study of aripiprazole in nonschizophrenic crack-dependent patients. (2008) (20)
Erratum: The European Study of the Epidemiology of Mental Disorders (ESEMedD) Project: Rationale and methods, ESEMeD/MHEDEA 2000 investigators (International Journal of Methods in Psychiatric Research (2003) vol. 11 (2) (55-67)) (2003) (20)
Patient satisfaction with psychotropic drugs: sensitivity to change and relationship to clinical status, quality-of-life, compliance and effectiveness of treatment. Results from a nation-wide 6-month prospective study (2006) (20)
Panic Disorder: Clinical Diagnosis, Management and Mechanisms (1998) (20)
Dysfunctional parental styles perceived during childhood in outpatients with substance use disorders (2013) (20)
[Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting]. (2009) (19)
Suicidal behavior and onset of panic disorder. (1991) (19)
The role of Criterion A 2 in the DSM-IV diagnosis of post-traumatic stress disorder (2011) (19)
Simple laboratory test of neuroendocrine disturbance in depression: 11 p.m. saliva cortisol. (1987) (18)
The role of religious advisors in mental health care in the World Mental Health surveys (2017) (18)
Alcohol abuse in developed and developing countries in the World Mental Health Surveys: Socially defined consequences or psychiatric disorder? (2014) (18)
Childhood generalized specific phobia as an early marker of internalizing psychopathology across the lifespan: results from the World Mental Health Surveys (2019) (18)
Screening for psychologically traumatized rape victims. (1998) (17)
[Prevalence and risk factors for suicide ideation, plans and attempts in the French general population: results from the ESEMeD study]. (2012) (17)
Moclobemide in Social Phobia: A Pilot Open Study (1994) (17)
Prevalence and severity of mental disorders in the World Mental Health Survey Initiative. (2008) (17)
Variability of response to methadone: genome-wide DNA methylation analysis in two independent cohorts. (2016) (17)
Associations between DSM-IV mental disorders and subsequent non-fatal, self-reported stroke. (2015) (16)
Cross-national patterns of substance use disorder treatment and associations with mental disorder comorbidity in the WHO World Mental Health Surveys. (2019) (16)
[Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice]. (2003) (16)
KCNH2 polymorphism and methadone dosage interact to enhance QT duration. (2014) (16)
Recovery from DSM-IV post-traumatic stress disorder in the WHO World Mental Health surveys (2017) (16)
Subtyping familial schizophrenia: Reliability, concordance, and stability (1990) (16)
Prospective assessment of transient cocaine-induced psychotic symptoms in a clinical setting. (2011) (16)
A comparison of DSM‐5 and DSM‐IV agoraphobia in the World Mental Health Surveys (2019) (16)
Clinical differences between unipolar and bipolar depression: interest of BDRS (Bipolar Depression Rating Scale). (2013) (15)
Civilians in World War II and DSM-IV mental disorders: results from the World Mental Health Survey Initiative (2018) (15)
Similarities and Differences Between Incestuous and Nonincestuous Rape in a French Follow-Up Study (1999) (15)
Lifetime history of panic attacks and epilepsy: an association from a general population survey. (1991) (14)
Childhood adversities and adult psychopathology in the WHO Material (2010) (14)
World Mental Health Surveys Childhood adversities and adult psychopathology in the WHO (2011) (14)
IRRITABLE MOOD IN ADULT MAJOR DEPRESSIVE DISORDER: RESULTS FROM THE WORLD MENTAL HEALTH SURVEYS (2013) (14)
Immunoglobulin sub-class distribution in bipolar disorder and schizophrenia: potential relationship with latent Toxoplasma Gondii infection (2018) (14)
Psychopathology in the 21st century (2010) (14)
Treating addictions with deep brain stimulation is premature but well-controlled clinical trials should be performed. (2011) (13)
Anxiolytic and hypnotic use by general hospital inpatients. The impact of psychopathology and general medical conditions. (1999) (13)
A double‐blind study of the efficacy and safety of sertraline and clomipramine in outpatients with severe major depression (2000) (13)
Relapsing-remitting behavioural variant of frontotemporal dementia in a bipolar patient. (2012) (13)
Cannabis expectancies in substance misusers: French validation of the Marijuana Effect Expectancy Questionnaire. (2011) (12)
Prevalence of recurrent brief depression in primary care (2005) (12)
[Dimensional personality assessment of the members of the French junior national team of road cycling]. (2003) (12)
An updated global picture of cigarette smoking persistence among adults (2012) (12)
[Pharmacotherapy in personality disorders: methodological issues and results]. (1999) (11)
Self-reported cue-induced physical symptoms of craving as an indicator of cocaine dependence. (2015) (11)
A European Perspective on Depression in the Community: The DEPRES Study (2002) (11)
Self-reported sleep disturbances during cannabis withdrawal in cannabis-dependent outpatients with and without opioid dependence. (2010) (11)
The Obsessive-Compulsive Cocaine Scale (OCCS): a pilot study of a new questionnaire for assessing cocaine craving. (2012) (11)
Recurrent brief depression: clinical and epidemiological issues. (1995) (11)
Comparing Mental Health of Francophones in Canada, France, and Belgium: 12-Month and Lifetime Rates of Mental Health Service Use (Part 2) (2010) (10)
Gender-specific study of recurrent suicide attempts in outpatients with multiple substance use disorders. (2018) (10)
QT length during methadone maintenance treatment: gene × dose interaction (2019) (9)
The prevalence of mental disorders and service use in France: results from a National Survey 2001-2002. (2008) (9)
Familial factors influencing the consumption of anxiolytics and hypnotics by children and adolescents (2001) (9)
Comparing Mental Health of Francophone Populations in Canada, France, and Belgium: 12-Month Prevalence Rates of Common Mental Disorders (Part 1) (2010) (9)
Childhood history of behavioral inhibition and comorbidity status in 256 adults with social phobia. (2011) (8)
Pharmacoepigenomics of opiates and methadone maintenance treatment: current data and perspectives. (2017) (8)
OPRM1 polymorphism and lifetime suicide attempts among stabilized, methadone-maintained outpatients (2014) (8)
Clinical Global Impression−Schizophrenia Scale (2016) (8)
Mephenesin dependence: a case series. (2012) (8)
Olanzapine and weight gain. (2000) (8)
Correction: Disability Mediates the Impact of Common Conditions on Perceived Health (2013) (8)
Perceived helpfulness of treatment for generalized anxiety disorder: a World Mental Health Surveys report (2021) (7)
Childhood trauma are not associated with the intensity of transient cocaine induced psychotic symptoms (2015) (7)
An observational study of benzodiazepine prescription during inpatient alcohol detoxification for patients with vs. without chronic pretreatment with high‐dosage baclofen (2018) (7)
The Epidemiology of Mood Disorders (2005) (7)
[Psychotropic drug use in France: changes over time and comparison with other European countries]. (2006) (7)
Anxiolytic and hypnotic use in 376 psychiatric inpatients (1999) (6)
Balneotherapy Together with a Psychoeducation Program for Benzodiazepine Withdrawal: A Feasibility Study (2016) (6)
Psychometric Properties of the Cannabis Use Disorders Identification Test in French Cannabis Misusers (2011) (6)
Anxiety disorders in a French general psychiatric outpatient sample (1989) (6)
[Social phobia: historical and conceptual perspectives]. (1995) (6)
Anxiety disorders are associated with early onset of heroin use and rapid transition to dependence in methadone maintained patients (2016) (6)
Early-onset mental disorders and their links to chronic physical conditions in adulthood. (2013) (5)
Smoking ban in a psychiatry department: Are nonsmoking employees less exposed to environmental tobacco smoke? (2009) (5)
[Changes in urinary levels of MHPG, VMA and 5-HIAA and plasma tryptophan in post-partum blues. Initial results]. (1985) (5)
The European study of the epidemiology of mental disorders (ESEMedD) project : rationale and methods (vol 11, pg 55, 2002) (2003) (5)
[When and how to detoxify clients from methadone maintenance treatment?]. (2013) (5)
The Identification of Psychiatric Disorders in Primary Care (1996) (5)
Therapeutic target for cognition enhancers: diagnosis and clinical phenomenology. (1990) (4)
90-75 A double-blind efficacy and safety study of sertraline and clomipramine in severe major depression (1997) (4)
Are empty methadone bottles empty? An analytic study (2014) (4)
P-12-11 Treatment of severe major depression: A double-blind study of sertraline and clomipramine (1996) (4)
Ictal mania: a case report. (2000) (4)
Onset of panic disorder and suicide attempts (1990) (4)
[Panic disorder and alcoholism: effects of comorbidity]. (1993) (4)
Relevance of treated cocaine users’ retrospective memory of first cocaine use (2018) (3)
Predictive value of baseline resistance in early response to antidepressants. (2014) (3)
DSM IV personality disorders in the WHO World Mental Health data (2009) (3)
Primary anxiety disorders (2003) (3)
[Chronology of the extrapyramidal effects of neuroleptics, and the nigrostriatal dopaminergic system]. (1979) (3)
[Cannabis withdrawal syndrome in patients with cannabis dependence only, and in patients with cannabis and opioid dependence]. (2011) (3)
Epidemiology and Public Health Impact of Anxiety Disorders in Late Life (1998) (3)
[Current pharmacotherapies and immunotherapy in cocaine addiction]. (2008) (3)
Corrigendum to associations between DSM-IV mental disorders and subsequent self-reported diagnosis of cancer [J Psychosom Res 76 (2014) 207-212] (2015) (3)
[Panic disorder and alcoholism]. (1991) (3)
14-55 Personality profiles in substance abusers using the temperament and character inventory (TCI) (1997) (2)
[Comorbidity of anxiety and depression: epidemiologic perspectives]. (1994) (2)
47-1 Diagnostic thresholds and definition of social phobia (1997) (2)
Occurrence and severity of cocaine-induced hallucinations: Two distinct phenotypes with shared clinical factors but specific genetic risk factors. (2022) (2)
Neonatal tuberculous meningitis in a patient with Asperger's syndrome. (2003) (2)
A case report of tramadol abuse-associated tics. (2010) (2)
[Usefulness of self-assessment scales for anxiety and depression in internal medicine]. (1986) (2)
[Days out of role due to common mental and physical disorders: French results from the WHO World Mental Health surveys]. (2014) (2)
[The European Schizophrenia Outpatient Health Outcomes Study: observational study over 36 months of the French cohort of schizophrenic outpatients treated with antipsychotics]. (2009) (2)
Prevalence, incidence and syndrome stability of generalized and non-generalized social phobia in adolescents and adults (1998) (2)
Cohort Alcohol Use in France and the Transition from Use to Alcohol Use Disorder and Remission (2019) (2)
[Depressive states: clinical symptoms and monoaminergic hypothesis]. (1978) (2)
[Prevalence of depressive symptoms in a population of ambulatory schizophrenics]. (1983) (2)
39-41 Anxiolytics-hypnotics use in children and adolescents and their parents (1997) (1)
[Dexamethasone test: diagnostic aid in delusional melancholia]. (1983) (1)
[Psychological trauma and mental disorders]. (1995) (1)
[Acute anxiety attack. Diagnostic orientation and management in an emergency situation]. (1998) (1)
The associations of serious mental illness with earnings in the WHO World Mental Health Surveys (2010) (1)
Psychological abnormalities are commonly present in adult patients with pulmonary Langerhans cell histiocytosis (2019) (1)
French Validation Study of the Temperament and Character Inventory (tci) in Healthy Volunteers (1996) (1)
Childhood adversities and adult psychopathology in the World Health Organization World Mental Health Surveys (2010) (1)
[Importance of bromocriptine in dysthymic schizophrenia]. (1978) (1)
P.2.b.026 Brain-derived neurotrophic factor Val66Met polymorphism and 6-month antidepressant remission in depressed Caucasian patients (2014) (1)
S-10-1 Subthreshold anxiety and depression disorders: Prevalence rates and needs for treatment (1996) (1)
[Is anxiety hereditary?]. (1988) (1)
S-17-1 Pharmacological treatment of anxiety disorders: An overview (1995) (1)
Consensus Statement on the Benefit to the Community of ESEMeD Survey Data on Depression and Anxiety (2007) (1)
Comorbid addiction in bipolar affective disorder (2012) (1)
[Panic disorder in patients consulting a cardiologist]. (1994) (1)
Transient Cocaine-Induced Chest Pain: A Case Series (2014) (1)
Number needed to treat (NNT) for all-cause medication discontinuation in catie compared to the schizophrenia outpatients health outcomes (SOHO) study (2007) (1)
[Plasma and saliva DST (dexamethasone suppression test) in depression. Clinical applications and kinetic approach]. (1984) (1)
90-150 Lithium self-poisoning and therapeutic intoxications (1997) (0)
Treatment of panic disorder: Algorithms for pharmacotherapy. (1997) (0)
Gender differences in schizophrenia: Results from the schizophrenia outpatient health outcomes study (SOHO) (2002) (0)
Letter to the Editor: Neonatal Tuberculous Meningitis in a Patient with Asperger's Syndrome (2003) (0)
Contents, Vol. 28, Supplement 1, 1995 (1995) (0)
Depression and Anxiety (2019) (0)
PANIC, PHOBIAS AND PERSONALITY (1992) (0)
[Obsessive compulsive disorder. Clinical and epidemiologic studies]. (1989) (0)
Preliminary baseline results from schizophrenia outpatient health outcomes study (SOHO): A 3-year, pan-European, observational health outcomes study in schizophrenia (2001) (0)
S.17.01 Social phobia: Treatment usage in general health care (1996) (0)
Clustering suicidal phenotypes and genetic associations with brain-derived neurotrophic factor in patients with substance use disorders (2021) (0)
The temperament and character inventory (TCI) in patients with substance use disorders: Comparative study with community subjects (1998) (0)
COMPARISON OF SURICLONE AND LORAZEPAM IN THE TREATMENT OF GENERALIZED ANXIETY DISORDERS IN THE ELDERLY (1992) (0)
[Value of the CAGE questionnaire in the screening of alcoholism]. (1990) (0)
P.5.034 Do women have more risk of relapse than men in primary alcoholism? (2003) (0)
COST INDICATORS IN DSM 3R DEPRESSIVE CASES FROM A FRENCH COMMUNITY SAMPLE. (1992) (0)
Preliminary results of the ESEMeD/MHEDEA 2000 study (2002) (0)
[Seborrheic alopecia and its treatment]. (1961) (0)
[Antidepressants, anxiety and depression disorders]. (1996) (0)
Social anxiety disorder across the globe (2021) (0)
How to obtain DNA from injection drug users? (2011) (0)
[Treatment of post-traumatic stress syndrome]. (1993) (0)
P-952 - Candidate Genes for Pharmacogenetic Management of Methadone Optimal Dose (2012) (0)
Diagnosis and epidemiology of social phobia (1993) (0)
Authors' reply (2007) (0)
Iconographies supplémentaires de l'article : Smoking ban in a psychiatry department: Are nonsmoking employees less exposed to environmental tobacco smoke? (2009) (0)
[Multiple diagnoses in psychiatry]. (1992) (0)
[Combinations and interactions in psychopharmacology]. (1981) (0)
[What is a predictive factor?]. (1991) (0)
Attention Deficit Hyperactivity Disorder (ADHD) and addictions in methadone-treated patients (2012) (0)
Erratum to: Associations between DSM-IV mental disorders and diabetes mellitus: a role for impulse control disorders and depression (2014) (0)
The Associations Between Mental Disorders and Subsequent Cancer (2014) (0)
[Panic disorder: syndrome or illness?]. (1994) (0)
C.03.04 Treatment of recurrence in depression: Long-term prevention of a chronic illness (2004) (0)
Psychiatric care and profile of schizophrenic outpatients treated by psychiatrists in France. French baseline results from the 3-years, pan-European, observational SOHO (Schizophrenia Outpatient Health Outcomes) study (2002) (0)
Genetics of Anxiety Disorders: Part II (2001) (0)
C.13.02 The neurobiological mechanisms and association of GAD and fibromyalgia (2008) (0)
A case report of transient but clinically relevant interaction between methadone and duloxetine: a reply to McCance-Katz et al. (2010) (0)
Childhood Trauma and the Severity of past Suicide Attempts in Outpatients with Cocaine Use Disorders (2021) (0)
Clinical status and tolerability profiles of previously untreated schizophrenia patients, 24 month from the pan-european SOHO (Schizophrenia Outpatient Health Outcomes) study (2005) (0)
Decision-making in cocaine dependence: Implication of opiate dependence and predictive value for relapse (2012) (0)
Alcool, substances psychoactives et psychopathologie (1999) (0)
[Anxiolytics and hypnotics use by psychiatric inpatients' children: preliminary study]. (1999) (0)
[What should be the duration of a treatment with antidepressive agents?]. (1994) (0)
SURICLONE AND MEMORY (1992) (0)
[Paranoid personality and sensitive personality]. (1986) (0)
Hospital Anxiety and Depression Scale--French Version (2016) (0)
Une dépression du post-partum (1988) (0)
Epidemiology of Social Phobia (1998) (0)
S-47-1 Chronic benzodiazepine use in the general population (1996) (0)
Olanzapine, risperidone or quetiapine treatment initiation: 12-month schizophrenia outpatient health outcomes (SOHO) study results (2004) (0)
[Antidepressive agents and anxiety]. (1991) (0)
P.6.a.010 Cognitive disorders among alcoholics: relevance of the Montreal Cognitive Assessment (2012) (0)
Substance misuse disguised as ADHD? Author's reply (2007) (0)
Factores predictivos del trastorno por estrés postraumático crónico en víctimas de violación (1999) (0)
SCREENING FOR ALCOHOL ABUSE AND DEPENDENCE IN MEDICAL INPATIENTS (1992) (0)
from the WHO World Mental Health surveys Associations of serious mental illness with earnings: results (2011) (0)
MOCLOBEMIDE IN SOCIAL PHOBIAS: AN OPEN STUDY (1992) (0)
P.3.053 Primary anxiety disorders: Impact of treatment on subsequent depression and health outcomes (2003) (0)

This paper list is powered by the following services:

Jean‐pierre Lépine's Academic­Influence.com Rankings

Jean‐pierre Lépine's Degrees

Why Is Jean‐pierre Lépine Influential?

Jean‐pierre Lépine's Published Works

Published Works

Jean‐pierre Lépine's AcademicInfluence.com Rankings